The same study demonstrated that ZEB1, a transcriptional repressor of IL-15, is unable to bind to the IL-15 promotor region in the cells of CTCL patients due to hypermethylation in this region of the gene transcript, resulting in overexpression of this cytokine [50]. The gene discussed is ZEB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.